S&P 500   2,978.76 (-4.42%)
DOW   25,766.64 (-4.42%)
QQQ   205.64 (-5.01%)
AAPL   273.52 (-6.54%)
FB   189.75 (-3.78%)
MSFT   158.18 (-7.05%)
GOOGL   1,314.95 (-5.43%)
AMZN   1,884.30 (-4.81%)
CGC   18.44 (-6.96%)
NVDA   252.60 (-5.62%)
BABA   205.03 (-1.78%)
MU   50.58 (-3.42%)
GE   10.39 (-5.11%)
TSLA   679.00 (-12.81%)
AMD   44.01 (-7.33%)
T   35.73 (-3.69%)
ACB   1.45 (-3.97%)
F   6.97 (-3.33%)
NFLX   371.71 (-1.99%)
PRI   114.78 (-4.46%)
BAC   29.13 (-4.90%)
DIS   118.04 (-4.31%)
GILD   72.66 (-2.73%)
S&P 500   2,978.76 (-4.42%)
DOW   25,766.64 (-4.42%)
QQQ   205.64 (-5.01%)
AAPL   273.52 (-6.54%)
FB   189.75 (-3.78%)
MSFT   158.18 (-7.05%)
GOOGL   1,314.95 (-5.43%)
AMZN   1,884.30 (-4.81%)
CGC   18.44 (-6.96%)
NVDA   252.60 (-5.62%)
BABA   205.03 (-1.78%)
MU   50.58 (-3.42%)
GE   10.39 (-5.11%)
TSLA   679.00 (-12.81%)
AMD   44.01 (-7.33%)
T   35.73 (-3.69%)
ACB   1.45 (-3.97%)
F   6.97 (-3.33%)
NFLX   371.71 (-1.99%)
PRI   114.78 (-4.46%)
BAC   29.13 (-4.90%)
DIS   118.04 (-4.31%)
GILD   72.66 (-2.73%)
S&P 500   2,978.76 (-4.42%)
DOW   25,766.64 (-4.42%)
QQQ   205.64 (-5.01%)
AAPL   273.52 (-6.54%)
FB   189.75 (-3.78%)
MSFT   158.18 (-7.05%)
GOOGL   1,314.95 (-5.43%)
AMZN   1,884.30 (-4.81%)
CGC   18.44 (-6.96%)
NVDA   252.60 (-5.62%)
BABA   205.03 (-1.78%)
MU   50.58 (-3.42%)
GE   10.39 (-5.11%)
TSLA   679.00 (-12.81%)
AMD   44.01 (-7.33%)
T   35.73 (-3.69%)
ACB   1.45 (-3.97%)
F   6.97 (-3.33%)
NFLX   371.71 (-1.99%)
PRI   114.78 (-4.46%)
BAC   29.13 (-4.90%)
DIS   118.04 (-4.31%)
GILD   72.66 (-2.73%)
S&P 500   2,978.76 (-4.42%)
DOW   25,766.64 (-4.42%)
QQQ   205.64 (-5.01%)
AAPL   273.52 (-6.54%)
FB   189.75 (-3.78%)
MSFT   158.18 (-7.05%)
GOOGL   1,314.95 (-5.43%)
AMZN   1,884.30 (-4.81%)
CGC   18.44 (-6.96%)
NVDA   252.60 (-5.62%)
BABA   205.03 (-1.78%)
MU   50.58 (-3.42%)
GE   10.39 (-5.11%)
TSLA   679.00 (-12.81%)
AMD   44.01 (-7.33%)
T   35.73 (-3.69%)
ACB   1.45 (-3.97%)
F   6.97 (-3.33%)
NFLX   371.71 (-1.99%)
PRI   114.78 (-4.46%)
BAC   29.13 (-4.90%)
DIS   118.04 (-4.31%)
GILD   72.66 (-2.73%)
Log in

NYSE:LH - Laboratory Corp. of America Stock Price, Forecast & News

$182.59
-1.01 (-0.55 %)
(As of 02/27/2020 04:00 PM ET)
Today's Range
$179.78
Now: $182.59
$187.35
50-Day Range
$173.84
MA: $182.44
$195.28
52-Week Range
$140.53
Now: $182.59
$196.36
Volume922,385 shs
Average Volume705,369 shs
Market Capitalization$17.73 billion
P/E Ratio21.84
Dividend YieldN/A
Beta1.07
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, LabCorp Diagnostics (LCD) and Covance Drug Development. It offers various clinical laboratory tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually-transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. Read More…

Industry, Sector and Symbol

Industry Medical laboratories
Sub-IndustryHealth Care Services
SectorMedical
CUSIP50540R40
Phone336-229-1127

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$11.55 billion
Cash Flow$17.26 per share
Book Value$77.93 per share

Profitability

Net Income$823.80 million

Miscellaneous

Employees61,000
Market Cap$17.73 billion
Next Earnings Date5/5/2020 (Estimated)
OptionableOptionable

Receive LH News and Ratings via Email

Sign-up to receive the latest news and ratings for LH and its competitors with MarketBeat's FREE daily newsletter.


Laboratory Corp. of America (NYSE:LH) Frequently Asked Questions

What is Laboratory Corp. of America's stock symbol?

Laboratory Corp. of America trades on the New York Stock Exchange (NYSE) under the ticker symbol "LH."

How were Laboratory Corp. of America's earnings last quarter?

Laboratory Corp. of America Holdings (NYSE:LH) released its earnings results on Thursday, February, 13th. The medical research company reported $2.86 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $2.80 by $0.06. The medical research company had revenue of $3 billion for the quarter, compared to analyst estimates of $2.92 billion. Laboratory Corp. of America had a net margin of 7.13% and a return on equity of 15.37%. The firm's quarterly revenue was up 7.6% compared to the same quarter last year. During the same quarter last year, the firm earned $2.52 EPS. View Laboratory Corp. of America's Earnings History.

When is Laboratory Corp. of America's next earnings date?

Laboratory Corp. of America is scheduled to release their next quarterly earnings announcement on Tuesday, May 5th 2020. View Earnings Estimates for Laboratory Corp. of America.

What guidance has Laboratory Corp. of America issued on next quarter's earnings?

Laboratory Corp. of America issued an update on its FY20 earnings guidance on Thursday, February, 13th. The company provided earnings per share guidance of $11.75-$12.15 for the period, compared to the Thomson Reuters consensus estimate of $11.97.

What price target have analysts set for LH?

14 Wall Street analysts have issued 1 year price targets for Laboratory Corp. of America's stock. Their forecasts range from $164.00 to $220.00. On average, they expect Laboratory Corp. of America's stock price to reach $197.11 in the next twelve months. This suggests a possible upside of 8.0% from the stock's current price. View Analyst Price Targets for Laboratory Corp. of America.

What is the consensus analysts' recommendation for Laboratory Corp. of America?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Laboratory Corp. of America in the last year. There are currently 2 sell ratings, 3 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Laboratory Corp. of America.

Has Laboratory Corp. of America been receiving favorable news coverage?

News headlines about LH stock have been trending somewhat negative on Thursday, InfoTrie Sentiment reports. InfoTrie identifies positive and negative news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Laboratory Corp. of America earned a media sentiment score of -1.7 on InfoTrie's scale. They also gave media coverage about the medical research company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for Laboratory Corp. of America.

Are investors shorting Laboratory Corp. of America?

Laboratory Corp. of America saw a increase in short interest in January. As of January 31st, there was short interest totalling 1,600,000 shares, an increase of 8.8% from the January 15th total of 1,470,000 shares. Based on an average trading volume of 605,800 shares, the days-to-cover ratio is currently 2.6 days. Approximately 1.7% of the shares of the stock are short sold. View Laboratory Corp. of America's Current Options Chain.

Who are some of Laboratory Corp. of America's key competitors?

What other stocks do shareholders of Laboratory Corp. of America own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Laboratory Corp. of America investors own include CA (CA), BlackRock (BLK), Amgen (AMGN), Micron Technology (MU), NVIDIA (NVDA), Gilead Sciences (GILD), Endologix (ELGX), Allergan (AGN), AT&T (T) and Chipotle Mexican Grill (CMG).

Who are Laboratory Corp. of America's key executives?

Laboratory Corp. of America's management team includes the folowing people:
  • Mr. David P. King, Chairman, CEO & Pres (Age 63)
  • Mr. Glenn A. Eisenberg, CFO & Exec. VP (Age 58)
  • Mr. F. Samuel Eberts III, Chief Legal Officer, Chief Compliance Officer, Sr. VP & Sec. (Age 59)
  • Mr. John D. Ratliff, Chief Exec. Officer of Covance Drug Devel. (Age 59)
  • Dr. Michelle Abelson, Laboratory Director of Operations

Who are Laboratory Corp. of America's major shareholders?

Laboratory Corp. of America's stock is owned by many different of institutional and retail investors. Top institutional shareholders include State Street Corp (4.49%), Franklin Resources Inc. (1.66%), Boston Partners (1.61%), UBS Asset Management Americas Inc. (1.57%), Geode Capital Management LLC (1.54%) and FMR LLC (1.44%). Company insiders that own Laboratory Corp. of America stock include David P King, Der Vaart Sandra D Van, Edward T Dodson, Glenn A Eisenberg, Jean-Luc Belingard, Kerrii B Anderson, Lance Berberian, Lisa J Uthgenannt, M Huff Gary, Mark S Schroeder, Peter J Wilkinson, R Sanders Williams and Robert E Mittelstaedt Jr. View Institutional Ownership Trends for Laboratory Corp. of America.

Which major investors are selling Laboratory Corp. of America stock?

LH stock was sold by a variety of institutional investors in the last quarter, including Raymond James & Associates, Golub Group LLC, Point72 Asset Management L.P., Amundi Pioneer Asset Management Inc., CI Investments Inc., Janus Henderson Group PLC, UBS Asset Management Americas Inc. and Boston Partners. Company insiders that have sold Laboratory Corp. of America company stock in the last year include David P King, Der Vaart Sandra D Van, Glenn A Eisenberg, Jean-Luc Belingard, Kerrii B Anderson, Lance Berberian, Lisa J Uthgenannt, Mark S Schroeder, Peter J Wilkinson, R Sanders Williams and Robert E Mittelstaedt Jr. View Insider Buying and Selling for Laboratory Corp. of America.

Which major investors are buying Laboratory Corp. of America stock?

LH stock was purchased by a variety of institutional investors in the last quarter, including Madison Asset Management LLC, Renaissance Technologies LLC, Hexavest Inc., Bank of New York Mellon Corp, Great West Life Assurance Co. Can, Assenagon Asset Management S.A., Teacher Retirement System of Texas and Man Group plc. View Insider Buying and Selling for Laboratory Corp. of America.

How do I buy shares of Laboratory Corp. of America?

Shares of LH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Laboratory Corp. of America's stock price today?

One share of LH stock can currently be purchased for approximately $182.59.

How big of a company is Laboratory Corp. of America?

Laboratory Corp. of America has a market capitalization of $17.73 billion and generates $11.55 billion in revenue each year. The medical research company earns $823.80 million in net income (profit) each year or $11.32 on an earnings per share basis. Laboratory Corp. of America employs 61,000 workers across the globe.View Additional Information About Laboratory Corp. of America.

What is Laboratory Corp. of America's official website?

The official website for Laboratory Corp. of America is http://www.labcorp.com/.

How can I contact Laboratory Corp. of America?

Laboratory Corp. of America's mailing address is 358 South Main Street, BURLINGTON NC, 27215. The medical research company can be reached via phone at 336-229-1127 or via email at [email protected]


MarketBeat Community Rating for Laboratory Corp. of America (NYSE LH)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  496 (Vote Outperform)
Underperform Votes:  547 (Vote Underperform)
Total Votes:  1,043
MarketBeat's community ratings are surveys of what our community members think about Laboratory Corp. of America and other stocks. Vote "Outperform" if you believe LH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/27/2020 by MarketBeat.com Staff

Featured Article: Profit Margin

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel